State-of-the-art pathology: new WHO classification, implications, and new developments.
To keep up with advances in central nervous system (CNS) tumor diagnosis and discovery of new entities, the classification of these tumors requires periodic review and revision. Since the initial 1979 publication from the World Health Organization (WHO) of Histological Typing of Tumours of the Central Nervous System, 3 further editions have been published, cataloging the advances in CNS tumor classification and diagnosis over the past 3 decades. In this article, we discuss select new additions to the current classification, including new diagnostic tools, differential diagnoses, and management implications.
Cunliffe
Clare H
CH
Office of the Medical Investigator, University of New Mexico, 700 Camino de Salud NE, Albuquerque, NM 87106, USA. clare@drcunliffe.com
Fischer
Ingeborg
I
Parag
Yoav
Y
Fowkes
Mary E
ME
D001932:Brain Neoplasms / Q000145:classification* / Q000175:diagnosis*; D003937:Diagnosis, Differential; D005910:Glioma / Q000145:classification* / Q000473:pathology*; D006801:Humans; D020288:Papilloma, Choroid Plexus / Q000145:classification / Q000473:pathology; D010336:Pathology / Q000592:standards*; D010870:Pineal Gland / Q000473:pathology*; D010871:Pinealoma / Q000145:classification / Q000473:pathology; D010911:Pituitary Neoplasms / Q000145:classification / Q000473:pathology; D014944:World Health Organization